Rebecca A. Slater-Millican
Leeds, ENG, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 23 publications
Deep-Learning Solution Providing Molecular Marker Subtyping of Breast Cancer Whole Slide Images: Protocol for a UK Clinical Service Evaluation Study.
Journal: JMIR research protocols
Published: April 30, 2025
A Deep-Learning Solution Identifies HER2 Negative Cases and Provides ER and PR Results From H&E-Stained Breast Cancer Specimens: A Blind Validation Study.
Journal: Clinical breast cancer
Published: November 18, 2024
Concordance of HER2-low scoring in breast carcinoma among expert pathologists in the United Kingdom and the republic of Ireland -on behalf of the UK national coordinating committee for breast pathology.
Journal: Breast (Edinburgh, Scotland)
Published: April 26, 2023
The frequency and clinical significance of centromere enumeration probe 17 alterations in human epidermal growth factor receptor 2 immunohistochemistry-equivocal invasive breast cancer.
Journal: Histopathology
Published: April 07, 2022
Transcriptome profiles of stem-like cells from primary breast cancers allow identification of ITGA7 as a predictive marker of chemotherapy response.
Journal: British journal of cancer
Published: February 23, 2021
Predictors of pathological complete response to neoadjuvant treatment and changes to post-neoadjuvant HER2 status in HER2-positive invasive breast cancer.
Journal: Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc
Published: October 26, 2020
Retrospective observational study of HER2 immunohistochemistry in borderline breast cancer patients undergoing neoadjuvant therapy, with an emphasis on Group 2 (HER2/CEP17 ratio ≥2.0, HER2 copy number <4.0 signals/cell) cases.
Journal: British journal of cancer
Published: October 18, 2020
Role of vacuum assisted excision in minimising overtreatment of ductal atypias.
Journal: European journal of radiology
Published: June 24, 2020
Digital pathology for primary diagnosis of screen-detected breast lesions - experimental data, validation and experience from four centres.
Journal: Histopathology
Published: November 25, 2019
MiR-19b non-canonical binding is directed by HuR and confers chemosensitivity through regulation of P-glycoprotein in breast cancer.
Journal: Biochimica et biophysica acta. Gene regulatory mechanisms
Published: May 16, 2018
Interobserver variation in the diagnosis of fibroepithelial lesions of the breast: a multicentre audit by digital pathology.
Journal: Journal of clinical pathology
Published: December 21, 2017
Digital pathology for the primary diagnosis of breast histopathological specimens: an innovative validation and concordance study on digital pathology validation and training.
Journal: Histopathology
Published: July 07, 2017
Last Updated: 09/26/2026